Dr David M Burke, PHD | |
Uss Ronald Reagan (cvn-76), Medical Department, Fpo, AP 96616 | |
(619) 545-0246 | |
Not Available |
Full Name | Dr David M Burke |
---|---|
Gender | Male |
Speciality | Psychologist - Counseling |
Location | Uss Ronald Reagan (cvn-76), Fpo, Armed Forces Pacific |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578549887 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC1900X | Psychologist - Counseling | (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr David M Burke, PHD Uss Ronald Reagan (cvn-76), Medical Department, Fpo, AP 96616 Ph: (619) 545-0246 | Dr David M Burke, PHD Uss Ronald Reagan (cvn-76), Medical Department, Fpo, AP 96616 Ph: (619) 545-0246 |
News Archive
A study combining tumor cells from patients with breast cancer with a laboratory model of blood vessel lining provides the most compelling evidence so far that a specific trio of cells is required for the spread of breast cancer. The findings could lead to better tests for predicting whether a woman's breast cancer will spread and to new anti-cancer therapies.
For a million American adults, living with type 1 diabetes means a constant need for insulin medication, blood sugar testing supplies and specialized care, to keep them healthy and prevent a crisis that could end up in an emergency room, a hospital bed or death.
As many as half of people infected with viral hepatitis have suffered discrimination and one-quarter admit that family members have avoided physical contact with them after finding out they had the infection. A shocking patient survey presented at The International Liver Congress 2015 has shown the devastating impact the infection has on their daily lives.
Genzyme announced today that it has filed a lawsuit in the District Court of Tel Aviv alleging that Transkaryotic Therapies Inc. has infringed Genzyme's Israeli patent No. 100,715, which covers certain cell culture processes involved in the manufacture of glucocerebrosidase.
Bayer HealthCare today announced data from the Phase III PATENT-1 pulmonary arterial hypertension (PAH) trial evaluating its investigational drug riociguat in both treatment-naive patients and those pre-treated with an endothelin receptor antagonist or an oral, inhaled or subcutaneous prostanoid.
› Verified 3 days ago
Daniel Northington, PHD Psychologist Medicare: Medicare Enrolled Practice Location: Nmrtc Okinawa, Psc 482, Fpo, AP 96362 Phone: 805-235-3425 | |
Dr. Odelia Nicole Mcfadden, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: Uss Carl Vinson, Unit 100111, Fpo, AP 96629 Phone: 267-709-3521 | |
Allison Conforte, M.ED., ED.S., PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: U.s. Nmrtc Yokosuka, Fpo, AP 96350 Phone: 315-243-8649 | |
Dr. Felecia D. Sheffield, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: Naf Atsugi Bldg 21, Atsugi, Japan, Fpo, AP 96306 Phone: 315-264-3958 | |
Dr. Ivan Ryota Irie, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: Psc 475 Box 1, Fpo, AP 96350 Phone: 315-243-5171 | |
Debra Hoffmann Houst, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: Medical Department, Uss Carl Vinson Cvn 70, Fpo, AP 96629 Phone: 757-953-5814 | |
Eguono Voke Akpoduado, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: U.s Nmrtc Yokosuka, Naval Hospital, Fpo, AP 96350 Phone: 315-243-8649 |